Top compounds associated with response to TXNDC17


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC -0.12 0.006
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.006
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC 0.097 0.006
mRNA paclitaxel gCSI pan-cancer AAC 0.15 0.006
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.096 0.007
mRNA avicin D CTRPv2 pan-cancer AAC 0.15 0.008
mRNA ATRA CTRPv2 pan-cancer AAC -0.095 0.008
mRNA Docetaxel gCSI pan-cancer AAC 0.15 0.008
mRNA AZD4547 CTRPv2 pan-cancer AAC -0.1 0.008
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.008
Download CSV